| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |